Published in Am Heart J on November 01, 1987
Diastolic time - frequency relation in the stress echo lab: filling timing and flow at different heart rates. Cardiovasc Ultrasound (2008) 1.69
The myocardial oxygen supply:demand index revisited. J Am Heart Assoc (2014) 0.80
Post-exercise contractility, diastolic function, and pressure: operator-independent sensor-based intelligent monitoring for heart failure telemedicine. Cardiovasc Ultrasound (2009) 0.79
Abnormal shortened diastolic time length at increasing heart rates in patients with abnormal exercise-induced increase in pulmonary artery pressure. Cardiovasc Ultrasound (2011) 0.75
Complementary and Synergic Role of Combined Beta-blockers and Ivabradine in Patients with Chronic Heart Failure and Depressed Systolic Function: A New Therapeutic Option? Card Fail Rev (2016) 0.75
Coronary artery fistulas in adults: incidence, angiographic characteristics, natural history. Cathet Cardiovasc Diagn (1995) 3.94
A critical review of the systolic time intervals. Circulation (1977) 3.34
Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony. Circulation (1989) 2.56
Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group. Circulation (1990) 2.22
The Marfan syndrome: abnormal aortic elastic properties. J Am Coll Cardiol (1991) 2.06
Distensibility of the ascending aorta: comparison of invasive and non-invasive techniques in healthy men and in men with coronary artery disease. Eur Heart J (1990) 1.79
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation (2000) 1.69
Fatal hemorrhage as a complication of neurofibromatosis. Vasc Surg (1972) 1.67
Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation (2000) 1.63
Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol (1984) 1.57
Effect of quinapril or metoprolol on heart rate variability in post-myocardial infarction patients. Am J Cardiol (1996) 1.51
Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure. Circulation (1983) 1.51
Influence of positive inotropic therapy on pulsatile hydraulic load and ventricular-vascular coupling in congestive heart failure. J Am Coll Cardiol (1990) 1.44
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Usefulness of systolic time intervals in coronary artery disease. Am J Cardiol (1976) 1.40
Safety and effectiveness of oral quinidine in cardioversion of persistent atrial fibrillation. J Cardiol (2001) 1.38
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. Circulation (1978) 1.35
Extent of myocardial fibrosis and cellular hypertrophy in dilated cardiomyopathy. Am J Cardiol (1986) 1.32
Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann Intern Med (1977) 1.30
Myocardial lactate production in patients with angina-like chest pain and angiographically normal coronary arteries and left ventricle. Am J Cardiol (1974) 1.29
A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nat Genet (1994) 1.28
Concentration-dependence of disopyramide binding to plasma protein and its influence on kinetics and dynamics. J Pharmacol Exp Ther (1981) 1.28
Metabolic studies in mitral valve prolapse syndrome. A neuroendocrine--cardiovascular process. Circulation (1980) 1.24
Linear relationship between electrical systole, mechanical systole, and heart rate. Chest (1981) 1.23
Aorto-left atrial fistula. A reversible cause of acute refractory heart failure. Chest (1997) 1.23
Human myocardial histologic characteristics in congestive heart failure. Circulation (1983) 1.23
The arrhythmogenic effects of caffeine in human beings. N Engl J Med (1983) 1.22
Cocaine-induced coronary-artery dissection. N Engl J Med (1994) 1.21
Prolonged atrial conduction. A major predisposing factor for the development of atrial flutter. Circulation (1978) 1.20
Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation (1984) 1.18
Tolerance to dobutamine after a 72 hour continuous infusion. Am J Med (1980) 1.17
Cardiovascular abnormalities associated with adult polycystic kidney disease. Ann Intern Med (1984) 1.16
The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure. Circulation (1977) 1.15
Evolution of a hereditary cardiac conduction and muscle disorder: a study involving a family with six generations affected. Circulation (1986) 1.14
Altered collagen composition in a prolapsing mitral valve with ruptured chordae tendineae. Am J Med (1979) 1.12
Sleep apnea: treatment with protriptyline. Neurology (1979) 1.12
Captopril in primary pulmonary hypertension. Circulation (1983) 1.12
Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion. Circulation (1979) 1.12
Cardiovascular effects of ophthalmic timolol. Ann Intern Med (1986) 1.10
Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol (1993) 1.09
Left atrial volume and function in valvular aortic stenosis. J Heart Valve Dis (1993) 1.09
Pressure-diameter relation of the human aorta. A new method of determination by the application of a special ultrasonic dimension catheter. Circulation (1995) 1.08
Hemodynamic changes after meals and placebo treatment in chronic congestive heart failure. Am J Cardiol (1986) 1.07
Effect of impaired vasa vasorum flow on the structure and mechanics of the thoracic aorta: implications for the pathogenesis of aortic dissection. Eur J Cardiothorac Surg (2000) 1.06
Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation (1995) 1.05
Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension. Ann Intern Med (1982) 1.04
The spectrum of cardiac defects in the Ehlers-Danlos syndrome, types I and III. Ann Intern Med (1980) 1.04
Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation (1997) 1.04
Aortic distensibility abnormalities in coronary artery disease. Am J Cardiol (1987) 1.03
The hemodynamic effects of ibopamine, a dopamine congener, in patients with congestive heart failure. Pharmacotherapy (1986) 1.02
Drugs five years later. Dobutamine. Ann Intern Med (1983) 1.02
Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose. Ann Intern Med (1981) 1.01
Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart (1999) 1.01
Dissimilar atrial rhythms. A patient with interatrial block. Br Heart J (1977) 1.01
Pheochromocytoma: catecholamine-mediated electrocardiographic changes mimicking ischemia. Am Heart J (1988) 1.00
Effects of left bundle branch block on the events of the cardiac cycle. Acta Cardiol (1988) 0.99
Shortening of electromechanical systole as a manifestation of excessive adrenergic stimulation in acute myocardial infarction. Circulation (1972) 0.98
Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. J Am Coll Cardiol (1998) 0.96
Persistent left superior vena cava: unusual wave contour of left jugular vein as the presenting feature. Am Heart J (1990) 0.96
The floppy, myxomatous mitral valve, mitral valve prolapse, and mitral regurgitation. Prog Cardiovasc Dis (1991) 0.96
Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study. J Am Coll Cardiol (1984) 0.93
Regional myocyte hypertrophy and increased interstitial myocardial fibrosis in hypertrophic cardiomyopathy. Am J Cardiol (1987) 0.93
Interatrial conduction (activation) times. Am J Cardiol (1979) 0.93
The noninvasive localization of ventricular pacing sites by radionuclide phase imaging. Circulation (1984) 0.92
Floppy mitral valve chordae tendineae: histopathologic alterations. Hum Pathol (1988) 0.92
Nitrate tolerance. Am Heart J (1985) 0.92
Spectrum of structural abnormalities in floppy mitral valve echocardiographic evaluation. Am Heart J (1996) 0.91
Magnesium content of serum, circulating mononuclear cells, skeletal muscle, and myocardium in congestive heart failure. Circulation (1989) 0.91
Effect of exercise training on antioxidant enzymes and cardiotoxicity of doxorubicin. J Appl Physiol (1985) (1985) 0.91
Cardiac evaluation of mitoxantrone. Cancer Treat Rep (1983) 0.90
The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. Am Heart J (1983) 0.90
Safety and rationale for continuation of propranolol therapy during coronary bypass operation. Ann Thorac Surg (1978) 0.89
Morphologic and functional characteristics of the heart in Friedreich's ataxia. Am J Med (1987) 0.89
The Marfan syndrome: cardiovascular physical findings and diagnostic correlates. Am Heart J (1992) 0.89
Stereoselective effects of disopyramide enantiomers in humans. J Cardiovasc Pharmacol (1987) 0.89
Hemodynamic-inotropic response to beta-blocker with intrinsic sympathomimetic activity in patients with congestive cardiomyopathy. Circulation (1986) 0.89
Early changes in human myocardial nuclei after doxorubicin. Cancer (1983) 0.88
Cardiovascular involvement in patients with beta-thalassemia major without cardiac iron overload. Int J Cardiol (2008) 0.88
Effect of increased adrenergic activity on the relationship between electrical and mechanical systole. Circulation (1981) 0.88
The effect of left atrial histology and dimension on P wave morphology. J Electrocardiol (1983) 0.88